Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer

Published:2011-03 Issue:3 Volume:77 Page:682-687
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Mountzios Ioannis,Bournakis Evangelos,Efstathiou Eleni,Varkaris Andreas,Wen Sijin,Chrisofos Michael,Deliveliotis Charalambos,Alamanis Christos,Anastasiou Ioannis,Constantinides Constantine,Karadimou Alexandra,Tsiatas Marinos,Papadimitriou Christos,Bamias Aristotelis,Dimopoulos Meletios A.

Publisher

Elsevier BV

Subject

Urology

Reference17 articles.

1. Intermittent chemotherapy for metastatic hormone refractory prostate cancer;Lin;Crit Rev Oncol Hematol,2007

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report;Goldenberg;Urology,1995

5. Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study;Higano;Urology,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol);Therapeutic Advances in Medical Oncology;2022-01

2. Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival;Advances in Therapy;2021-05-27

3. 2020 Korean guidelines for the management of metastatic prostate cancer;The Korean Journal of Internal Medicine;2021-05-01

4. Maintenance Long-Term Multiple Cycles Treatment with Docetaxel in Metastatic Castration-Resistant Prostate Cancer: A Report of Three Cases;OncoTargets and Therapy;2021-04

5. Docetaxel Rechallenge in Patients with Metastatic Prostate Cancer: A Comprehensive Review;Oncology Research and Treatment;2020